Robitussin cough syrup recalled by Haleon in US due to contamination
Robitussin is frequently used to treat respiratory allergies, flu, cold, fever
Robitussin cough syrup supplied nationally is being recalled by Haleon owing to microbial contamination that may cause fatal infections in susceptible individuals, the US division of the global consumer health company based in the UK announced this week.
"Use of the recalled products could potentially result in severe or life-threatening fungal infections in those with impaired immune systems," Haleon stated in a notice posted by the Food and Drug Administration, according to CBS.
"Most users are unlikely to experience a serious health problem, but an infection that requiring medical intervention can't be ruled out," the company said.
Robitussin is frequently used to treat respiratory allergies, the common cold, the flu, and hay fever. The following goods are included in the recall, along with their lot numbers and expiration dates:
Robitussin Honey CF Max Day Adult 4oz — T10810 — October 31, 2025
Robitussin Honey CF Max Day Adult 8oz — T08730, T08731, T08732, T08733 — May 31, 2025
Robitussin Honey CF Max Day Adult 8oz — T10808 — September 30, 2025
Robitussin Honey CF Max NT Adult 8oz — T08740, T08742 — June 30, 2026
"Consumers who purchased the recalled products shouldn't use them," Haleon said.
-
AI boom pushes SK Hynix toward $1 trillion market valuation
-
US, EU lawmakers pledge scrutiny over Paramount-Warner Bros. deal
-
Meningitis leaves one dead, others critically ill; Know how it spreads
-
US lawmakers debate major cryptocurrency regulation proposal
-
How to use FHA financing: A 2026 guide to qualifications & benefits
-
US businesses hit by soaring wholesale inflation as fuel prices climb
-
'Robots are the Future': British tech firm Humanoid targets US IPO by 2030
-
Iran war could cost US taxpayers $1 trillion, expert warns